SCHEMBL7974486

SCHEMBL7974486

CC(C)(C)c1ccc(Cn2cnc3nc(-c4ccccc4)[nH]c(=O)c32)cc1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.50
ALDH1A1 P00352 2/20 0.50
HPGD P15428 1/20 0.50
KMT2A Q03164 1/20 0.49
TNKS O95271 4/20 0.48
TNKS2 Q9H2K2 4/20 0.48
ABCC8 Q09428 1/20 0.47
KCNJ11 Q14654 1/20 0.47
NR1H4 Q96RI1 2/20 0.41
ADORA3 P0DMS8 2/20 0.40
PARP1 P09874 2/20 0.40
BRD4 O60885 1/20 0.40
ADORA2B P29275 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
METAP2 P50579 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988517 0.90 ABCC8 (0.47) SMN1; SMN2ALDH1A1HPGDKMT2ATNKS
SCHEMBL7984930 0.90 ABCC8 (0.47) SMN1; SMN2ALDH1A1HPGDKMT2ATNKS
SCHEMBL7987359 0.89 TNKS (0.48) SMN1; SMN2ALDH1A1HPGDKMT2ATNKS
SCHEMBL7987948 0.89 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1HPGDKMT2ATNKS
SCHEMBL7974236 0.89 ABCC8 (0.43) SMN1; SMN2ALDH1A1HPGDKMT2ATNKS
SCHEMBL7991397 0.89 ABCC8 (0.43) SMN1; SMN2ALDH1A1HPGDKMT2ATNKS
SCHEMBL7985008 0.89 ABCC8 (0.43) SMN1; SMN2ALDH1A1HPGDKMT2ATNKS
SCHEMBL7975265 0.89 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1HPGDKMT2ATNKS
SCHEMBL8056958 0.88 SMN1; SMN2 (0.52) SMN1; SMN2ALDH1A1HPGDKMT2ATNKS
SCHEMBL7974275 0.88 HPGD (0.43) SMN1; SMN2ALDH1A1HPGDKMT2ATNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed